nodes	percent_of_prediction	percent_of_DWPC	metapath
Tadalafil—CYP3A4—Sibutramine—obesity	0.109	0.27	CbGbCtD
Tadalafil—CYP3A4—Benzphetamine—obesity	0.0824	0.204	CbGbCtD
Tadalafil—CYP3A4—Bupropion—obesity	0.0701	0.174	CbGbCtD
Tadalafil—CYP3A4—Orlistat—obesity	0.0571	0.142	CbGbCtD
Tadalafil—CYP3A4—Cimetidine—obesity	0.0514	0.127	CbGbCtD
Tadalafil—CYP3A4—Topiramate—obesity	0.0337	0.0834	CbGbCtD
Tadalafil—PDE11A—adrenal gland—obesity	0.00461	0.178	CbGeAlD
Tadalafil—PDE11A—endocrine gland—obesity	0.004	0.155	CbGeAlD
Tadalafil—PDE11A—liver—obesity	0.00361	0.139	CbGeAlD
Tadalafil—PDE5A—respiratory system—obesity	0.0029	0.112	CbGeAlD
Tadalafil—PDE5A—cardiovascular system—obesity	0.00222	0.0857	CbGeAlD
Tadalafil—PDE5A—adipose tissue—obesity	0.00196	0.0756	CbGeAlD
Tadalafil—PDE5A—digestive system—obesity	0.00184	0.0711	CbGeAlD
Tadalafil—PDE5A—adrenal gland—obesity	0.00176	0.0678	CbGeAlD
Tadalafil—PDE5A—endocrine gland—obesity	0.00152	0.0588	CbGeAlD
Tadalafil—CYP3A4—digestive system—obesity	0.000574	0.0222	CbGeAlD
Tadalafil—Nasal congestion—Topiramate—obesity	0.000535	0.00146	CcSEcCtD
Tadalafil—Rash—Diethylpropion—obesity	0.000535	0.00146	CcSEcCtD
Tadalafil—Dermatitis—Diethylpropion—obesity	0.000534	0.00146	CcSEcCtD
Tadalafil—Dizziness—Cimetidine—obesity	0.000534	0.00145	CcSEcCtD
Tadalafil—Haemoglobin—Bupropion—obesity	0.000532	0.00145	CcSEcCtD
Tadalafil—Headache—Diethylpropion—obesity	0.000531	0.00145	CcSEcCtD
Tadalafil—Rhinitis—Bupropion—obesity	0.000531	0.00145	CcSEcCtD
Tadalafil—Haemorrhage—Bupropion—obesity	0.000529	0.00144	CcSEcCtD
Tadalafil—Back pain—Orlistat—obesity	0.000528	0.00144	CcSEcCtD
Tadalafil—Hypoaesthesia—Bupropion—obesity	0.000527	0.00144	CcSEcCtD
Tadalafil—Pharyngitis—Bupropion—obesity	0.000525	0.00143	CcSEcCtD
Tadalafil—Muscle spasms—Orlistat—obesity	0.000525	0.00143	CcSEcCtD
Tadalafil—Urinary tract disorder—Bupropion—obesity	0.000523	0.00142	CcSEcCtD
Tadalafil—Oedema peripheral—Bupropion—obesity	0.000521	0.00142	CcSEcCtD
Tadalafil—Hot flush—Topiramate—obesity	0.000521	0.00142	CcSEcCtD
Tadalafil—Connective tissue disorder—Bupropion—obesity	0.00052	0.00142	CcSEcCtD
Tadalafil—Urethral disorder—Bupropion—obesity	0.000519	0.00141	CcSEcCtD
Tadalafil—Amnesia—Topiramate—obesity	0.000519	0.00141	CcSEcCtD
Tadalafil—Menopausal symptoms—Topiramate—obesity	0.000517	0.00141	CcSEcCtD
Tadalafil—Vision blurred—Orlistat—obesity	0.000515	0.0014	CcSEcCtD
Tadalafil—Vomiting—Cimetidine—obesity	0.000513	0.0014	CcSEcCtD
Tadalafil—Back pain—Sibutramine—obesity	0.000511	0.00139	CcSEcCtD
Tadalafil—Rash—Cimetidine—obesity	0.000509	0.00139	CcSEcCtD
Tadalafil—Dermatitis—Cimetidine—obesity	0.000509	0.00139	CcSEcCtD
Tadalafil—Muscle spasms—Sibutramine—obesity	0.000508	0.00138	CcSEcCtD
Tadalafil—Headache—Cimetidine—obesity	0.000506	0.00138	CcSEcCtD
Tadalafil—Nausea—Diethylpropion—obesity	0.000504	0.00137	CcSEcCtD
Tadalafil—Erythema multiforme—Bupropion—obesity	0.0005	0.00136	CcSEcCtD
Tadalafil—Angioedema—Orlistat—obesity	0.000499	0.00136	CcSEcCtD
Tadalafil—Vision blurred—Sibutramine—obesity	0.000498	0.00136	CcSEcCtD
Tadalafil—Eye disorder—Bupropion—obesity	0.000495	0.00135	CcSEcCtD
Tadalafil—Tinnitus—Bupropion—obesity	0.000493	0.00134	CcSEcCtD
Tadalafil—Cardiac disorder—Bupropion—obesity	0.000491	0.00134	CcSEcCtD
Tadalafil—Flushing—Bupropion—obesity	0.000491	0.00134	CcSEcCtD
Tadalafil—Vertigo—Orlistat—obesity	0.000491	0.00134	CcSEcCtD
Tadalafil—Pain in extremity—Topiramate—obesity	0.000487	0.00133	CcSEcCtD
Tadalafil—Angioedema—Sibutramine—obesity	0.000483	0.00132	CcSEcCtD
Tadalafil—Palpitations—Orlistat—obesity	0.000483	0.00132	CcSEcCtD
Tadalafil—Angiopathy—Bupropion—obesity	0.00048	0.00131	CcSEcCtD
Tadalafil—Migraine—Topiramate—obesity	0.00048	0.00131	CcSEcCtD
Tadalafil—Nausea—Cimetidine—obesity	0.000479	0.00131	CcSEcCtD
Tadalafil—Immune system disorder—Bupropion—obesity	0.000478	0.0013	CcSEcCtD
Tadalafil—Mediastinal disorder—Bupropion—obesity	0.000477	0.0013	CcSEcCtD
Tadalafil—Cough—Orlistat—obesity	0.000477	0.0013	CcSEcCtD
Tadalafil—Vertigo—Sibutramine—obesity	0.000475	0.00129	CcSEcCtD
Tadalafil—CYP3A4—endocrine gland—obesity	0.000475	0.0183	CbGeAlD
Tadalafil—Syncope—Sibutramine—obesity	0.000474	0.00129	CcSEcCtD
Tadalafil—Convulsion—Orlistat—obesity	0.000473	0.00129	CcSEcCtD
Tadalafil—Face oedema—Topiramate—obesity	0.000471	0.00128	CcSEcCtD
Tadalafil—Palpitations—Sibutramine—obesity	0.000467	0.00127	CcSEcCtD
Tadalafil—Myalgia—Orlistat—obesity	0.000465	0.00127	CcSEcCtD
Tadalafil—Chest pain—Orlistat—obesity	0.000465	0.00127	CcSEcCtD
Tadalafil—Loss of consciousness—Sibutramine—obesity	0.000464	0.00127	CcSEcCtD
Tadalafil—Mental disorder—Bupropion—obesity	0.000464	0.00126	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000462	0.00126	CcSEcCtD
Tadalafil—Cough—Sibutramine—obesity	0.000461	0.00126	CcSEcCtD
Tadalafil—Discomfort—Orlistat—obesity	0.000459	0.00125	CcSEcCtD
Tadalafil—Convulsion—Sibutramine—obesity	0.000458	0.00125	CcSEcCtD
Tadalafil—Hypertension—Sibutramine—obesity	0.000456	0.00124	CcSEcCtD
Tadalafil—Dry mouth—Orlistat—obesity	0.000455	0.00124	CcSEcCtD
Tadalafil—Liver function test abnormal—Topiramate—obesity	0.00045	0.00123	CcSEcCtD
Tadalafil—Arthralgia—Sibutramine—obesity	0.00045	0.00123	CcSEcCtD
Tadalafil—Chest pain—Sibutramine—obesity	0.00045	0.00123	CcSEcCtD
Tadalafil—Myalgia—Sibutramine—obesity	0.00045	0.00123	CcSEcCtD
Tadalafil—Oedema—Orlistat—obesity	0.000446	0.00121	CcSEcCtD
Tadalafil—Back pain—Bupropion—obesity	0.000446	0.00121	CcSEcCtD
Tadalafil—Orthostatic hypotension—Topiramate—obesity	0.000445	0.00121	CcSEcCtD
Tadalafil—Abdominal pain upper—Topiramate—obesity	0.000445	0.00121	CcSEcCtD
Tadalafil—Discomfort—Sibutramine—obesity	0.000445	0.00121	CcSEcCtD
Tadalafil—Muscle spasms—Bupropion—obesity	0.000443	0.00121	CcSEcCtD
Tadalafil—Infection—Orlistat—obesity	0.000443	0.00121	CcSEcCtD
Tadalafil—Breast disorder—Topiramate—obesity	0.00044	0.0012	CcSEcCtD
Tadalafil—Dry mouth—Sibutramine—obesity	0.00044	0.0012	CcSEcCtD
Tadalafil—Nervous system disorder—Orlistat—obesity	0.000437	0.00119	CcSEcCtD
Tadalafil—Nasopharyngitis—Topiramate—obesity	0.000436	0.00119	CcSEcCtD
Tadalafil—Vision blurred—Bupropion—obesity	0.000434	0.00118	CcSEcCtD
Tadalafil—Skin disorder—Orlistat—obesity	0.000433	0.00118	CcSEcCtD
Tadalafil—Gastritis—Topiramate—obesity	0.000431	0.00118	CcSEcCtD
Tadalafil—Oedema—Sibutramine—obesity	0.000431	0.00118	CcSEcCtD
Tadalafil—Hyperhidrosis—Orlistat—obesity	0.000431	0.00117	CcSEcCtD
Tadalafil—Infection—Sibutramine—obesity	0.000428	0.00117	CcSEcCtD
Tadalafil—CYP3A4—liver—obesity	0.000428	0.0165	CbGeAlD
Tadalafil—Shock—Sibutramine—obesity	0.000424	0.00116	CcSEcCtD
Tadalafil—Dysphagia—Topiramate—obesity	0.000421	0.00115	CcSEcCtD
Tadalafil—Angioedema—Bupropion—obesity	0.000421	0.00115	CcSEcCtD
Tadalafil—Tachycardia—Sibutramine—obesity	0.000421	0.00115	CcSEcCtD
Tadalafil—Skin disorder—Sibutramine—obesity	0.000419	0.00114	CcSEcCtD
Tadalafil—Hyperhidrosis—Sibutramine—obesity	0.000417	0.00114	CcSEcCtD
Tadalafil—Vertigo—Bupropion—obesity	0.000414	0.00113	CcSEcCtD
Tadalafil—Syncope—Bupropion—obesity	0.000413	0.00113	CcSEcCtD
Tadalafil—Angina pectoris—Topiramate—obesity	0.00041	0.00112	CcSEcCtD
Tadalafil—Palpitations—Bupropion—obesity	0.000407	0.00111	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Orlistat—obesity	0.000406	0.00111	CcSEcCtD
Tadalafil—Bronchitis—Topiramate—obesity	0.000405	0.0011	CcSEcCtD
Tadalafil—Loss of consciousness—Bupropion—obesity	0.000405	0.0011	CcSEcCtD
Tadalafil—Abdominal discomfort—Topiramate—obesity	0.000404	0.0011	CcSEcCtD
Tadalafil—Insomnia—Orlistat—obesity	0.000403	0.0011	CcSEcCtD
Tadalafil—Hypotension—Sibutramine—obesity	0.000403	0.0011	CcSEcCtD
Tadalafil—Cough—Bupropion—obesity	0.000402	0.0011	CcSEcCtD
Tadalafil—Paraesthesia—Orlistat—obesity	0.0004	0.00109	CcSEcCtD
Tadalafil—Convulsion—Bupropion—obesity	0.000399	0.00109	CcSEcCtD
Tadalafil—Hypertension—Bupropion—obesity	0.000398	0.00108	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Sibutramine—obesity	0.000393	0.00107	CcSEcCtD
Tadalafil—Dyspepsia—Orlistat—obesity	0.000392	0.00107	CcSEcCtD
Tadalafil—Chest pain—Bupropion—obesity	0.000392	0.00107	CcSEcCtD
Tadalafil—Arthralgia—Bupropion—obesity	0.000392	0.00107	CcSEcCtD
Tadalafil—Myalgia—Bupropion—obesity	0.000392	0.00107	CcSEcCtD
Tadalafil—Upper respiratory tract infection—Topiramate—obesity	0.000392	0.00107	CcSEcCtD
Tadalafil—Insomnia—Sibutramine—obesity	0.00039	0.00106	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.00039	0.00106	CcSEcCtD
Tadalafil—Discomfort—Bupropion—obesity	0.000388	0.00106	CcSEcCtD
Tadalafil—Paraesthesia—Sibutramine—obesity	0.000387	0.00106	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Orlistat—obesity	0.000385	0.00105	CcSEcCtD
Tadalafil—Dyspnoea—Sibutramine—obesity	0.000385	0.00105	CcSEcCtD
Tadalafil—Fatigue—Orlistat—obesity	0.000384	0.00105	CcSEcCtD
Tadalafil—Dry mouth—Bupropion—obesity	0.000384	0.00105	CcSEcCtD
Tadalafil—Somnolence—Sibutramine—obesity	0.000383	0.00105	CcSEcCtD
Tadalafil—Pain—Orlistat—obesity	0.000381	0.00104	CcSEcCtD
Tadalafil—Dyspepsia—Sibutramine—obesity	0.00038	0.00103	CcSEcCtD
Tadalafil—Oedema—Bupropion—obesity	0.000376	0.00102	CcSEcCtD
Tadalafil—Infestation NOS—Topiramate—obesity	0.000376	0.00102	CcSEcCtD
Tadalafil—Infestation—Topiramate—obesity	0.000376	0.00102	CcSEcCtD
Tadalafil—Infection—Bupropion—obesity	0.000374	0.00102	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Topiramate—obesity	0.000372	0.00101	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Sibutramine—obesity	0.000372	0.00101	CcSEcCtD
Tadalafil—Shock—Bupropion—obesity	0.00037	0.00101	CcSEcCtD
Tadalafil—Renal failure—Topiramate—obesity	0.000369	0.00101	CcSEcCtD
Tadalafil—Pain—Sibutramine—obesity	0.000369	0.00101	CcSEcCtD
Tadalafil—Constipation—Sibutramine—obesity	0.000369	0.00101	CcSEcCtD
Tadalafil—Nervous system disorder—Bupropion—obesity	0.000369	0.001	CcSEcCtD
Tadalafil—Tachycardia—Bupropion—obesity	0.000367	0.001	CcSEcCtD
Tadalafil—Skin disorder—Bupropion—obesity	0.000365	0.000995	CcSEcCtD
Tadalafil—Urinary tract infection—Topiramate—obesity	0.000365	0.000995	CcSEcCtD
Tadalafil—Conjunctivitis—Topiramate—obesity	0.000365	0.000995	CcSEcCtD
Tadalafil—Gastrointestinal pain—Orlistat—obesity	0.000364	0.000993	CcSEcCtD
Tadalafil—Hyperhidrosis—Bupropion—obesity	0.000363	0.000991	CcSEcCtD
Tadalafil—Haematuria—Topiramate—obesity	0.000358	0.000976	CcSEcCtD
Tadalafil—Epistaxis—Topiramate—obesity	0.000354	0.000966	CcSEcCtD
Tadalafil—Urticaria—Orlistat—obesity	0.000354	0.000965	CcSEcCtD
Tadalafil—Gastrointestinal pain—Sibutramine—obesity	0.000353	0.000961	CcSEcCtD
Tadalafil—Abdominal pain—Orlistat—obesity	0.000352	0.00096	CcSEcCtD
Tadalafil—Hypotension—Bupropion—obesity	0.000351	0.000958	CcSEcCtD
Tadalafil—Urticaria—Sibutramine—obesity	0.000343	0.000934	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Bupropion—obesity	0.000343	0.000934	CcSEcCtD
Tadalafil—Abdominal pain—Sibutramine—obesity	0.000341	0.000929	CcSEcCtD
Tadalafil—Insomnia—Bupropion—obesity	0.00034	0.000927	CcSEcCtD
Tadalafil—Haemoglobin—Topiramate—obesity	0.000339	0.000924	CcSEcCtD
Tadalafil—Rhinitis—Topiramate—obesity	0.000338	0.000921	CcSEcCtD
Tadalafil—Paraesthesia—Bupropion—obesity	0.000338	0.00092	CcSEcCtD
Tadalafil—Haemorrhage—Topiramate—obesity	0.000337	0.000919	CcSEcCtD
Tadalafil—Hypoaesthesia—Topiramate—obesity	0.000335	0.000914	CcSEcCtD
Tadalafil—Dyspnoea—Bupropion—obesity	0.000335	0.000914	CcSEcCtD
Tadalafil—Pharyngitis—Topiramate—obesity	0.000335	0.000912	CcSEcCtD
Tadalafil—Somnolence—Bupropion—obesity	0.000334	0.000911	CcSEcCtD
Tadalafil—Urinary tract disorder—Topiramate—obesity	0.000333	0.000908	CcSEcCtD
Tadalafil—Oedema peripheral—Topiramate—obesity	0.000332	0.000905	CcSEcCtD
Tadalafil—Connective tissue disorder—Topiramate—obesity	0.000331	0.000903	CcSEcCtD
Tadalafil—Dyspepsia—Bupropion—obesity	0.000331	0.000902	CcSEcCtD
Tadalafil—Urethral disorder—Topiramate—obesity	0.000331	0.000901	CcSEcCtD
Tadalafil—Hypersensitivity—Orlistat—obesity	0.000328	0.000895	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Bupropion—obesity	0.000325	0.000885	CcSEcCtD
Tadalafil—Fatigue—Bupropion—obesity	0.000324	0.000884	CcSEcCtD
Tadalafil—Pain—Bupropion—obesity	0.000322	0.000876	CcSEcCtD
Tadalafil—Constipation—Bupropion—obesity	0.000322	0.000876	CcSEcCtD
Tadalafil—Asthenia—Orlistat—obesity	0.00032	0.000871	CcSEcCtD
Tadalafil—Erythema multiforme—Topiramate—obesity	0.000319	0.000869	CcSEcCtD
Tadalafil—Hypersensitivity—Sibutramine—obesity	0.000318	0.000866	CcSEcCtD
Tadalafil—Pruritus—Orlistat—obesity	0.000315	0.000859	CcSEcCtD
Tadalafil—Eye disorder—Topiramate—obesity	0.000315	0.000859	CcSEcCtD
Tadalafil—Tinnitus—Topiramate—obesity	0.000314	0.000857	CcSEcCtD
Tadalafil—Flushing—Topiramate—obesity	0.000313	0.000853	CcSEcCtD
Tadalafil—Cardiac disorder—Topiramate—obesity	0.000313	0.000853	CcSEcCtD
Tadalafil—Asthenia—Sibutramine—obesity	0.000309	0.000843	CcSEcCtD
Tadalafil—Gastrointestinal pain—Bupropion—obesity	0.000307	0.000838	CcSEcCtD
Tadalafil—Angiopathy—Topiramate—obesity	0.000306	0.000834	CcSEcCtD
Tadalafil—Pruritus—Sibutramine—obesity	0.000305	0.000832	CcSEcCtD
Tadalafil—Diarrhoea—Orlistat—obesity	0.000305	0.000831	CcSEcCtD
Tadalafil—Immune system disorder—Topiramate—obesity	0.000305	0.00083	CcSEcCtD
Tadalafil—Mediastinal disorder—Topiramate—obesity	0.000304	0.000828	CcSEcCtD
Tadalafil—Urticaria—Bupropion—obesity	0.000299	0.000814	CcSEcCtD
Tadalafil—Abdominal pain—Bupropion—obesity	0.000297	0.00081	CcSEcCtD
Tadalafil—Mental disorder—Topiramate—obesity	0.000295	0.000805	CcSEcCtD
Tadalafil—Diarrhoea—Sibutramine—obesity	0.000295	0.000804	CcSEcCtD
Tadalafil—Dizziness—Orlistat—obesity	0.000295	0.000803	CcSEcCtD
Tadalafil—Dizziness—Sibutramine—obesity	0.000285	0.000777	CcSEcCtD
Tadalafil—Back pain—Topiramate—obesity	0.000284	0.000774	CcSEcCtD
Tadalafil—Vomiting—Orlistat—obesity	0.000283	0.000772	CcSEcCtD
Tadalafil—Muscle spasms—Topiramate—obesity	0.000282	0.000769	CcSEcCtD
Tadalafil—Rash—Orlistat—obesity	0.000281	0.000766	CcSEcCtD
Tadalafil—Dermatitis—Orlistat—obesity	0.000281	0.000765	CcSEcCtD
Tadalafil—Headache—Orlistat—obesity	0.000279	0.000761	CcSEcCtD
Tadalafil—Hypersensitivity—Bupropion—obesity	0.000277	0.000755	CcSEcCtD
Tadalafil—Vision blurred—Topiramate—obesity	0.000277	0.000754	CcSEcCtD
Tadalafil—Vomiting—Sibutramine—obesity	0.000274	0.000747	CcSEcCtD
Tadalafil—Rash—Sibutramine—obesity	0.000272	0.000741	CcSEcCtD
Tadalafil—Dermatitis—Sibutramine—obesity	0.000272	0.00074	CcSEcCtD
Tadalafil—Headache—Sibutramine—obesity	0.00027	0.000736	CcSEcCtD
Tadalafil—Asthenia—Bupropion—obesity	0.00027	0.000735	CcSEcCtD
Tadalafil—Pruritus—Bupropion—obesity	0.000266	0.000725	CcSEcCtD
Tadalafil—Nausea—Orlistat—obesity	0.000265	0.000721	CcSEcCtD
Tadalafil—Vertigo—Topiramate—obesity	0.000264	0.000719	CcSEcCtD
Tadalafil—Syncope—Topiramate—obesity	0.000263	0.000717	CcSEcCtD
Tadalafil—Palpitations—Topiramate—obesity	0.000259	0.000707	CcSEcCtD
Tadalafil—Loss of consciousness—Topiramate—obesity	0.000258	0.000703	CcSEcCtD
Tadalafil—Diarrhoea—Bupropion—obesity	0.000257	0.000701	CcSEcCtD
Tadalafil—Nausea—Sibutramine—obesity	0.000256	0.000698	CcSEcCtD
Tadalafil—Cough—Topiramate—obesity	0.000256	0.000698	CcSEcCtD
Tadalafil—Convulsion—Topiramate—obesity	0.000254	0.000693	CcSEcCtD
Tadalafil—Hypertension—Topiramate—obesity	0.000253	0.000691	CcSEcCtD
Tadalafil—Arthralgia—Topiramate—obesity	0.00025	0.000681	CcSEcCtD
Tadalafil—Chest pain—Topiramate—obesity	0.00025	0.000681	CcSEcCtD
Tadalafil—Myalgia—Topiramate—obesity	0.00025	0.000681	CcSEcCtD
Tadalafil—Dizziness—Bupropion—obesity	0.000249	0.000678	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000248	0.000676	CcSEcCtD
Tadalafil—Discomfort—Topiramate—obesity	0.000247	0.000673	CcSEcCtD
Tadalafil—Dry mouth—Topiramate—obesity	0.000244	0.000666	CcSEcCtD
Tadalafil—Oedema—Topiramate—obesity	0.00024	0.000653	CcSEcCtD
Tadalafil—Vomiting—Bupropion—obesity	0.000239	0.000652	CcSEcCtD
Tadalafil—Infection—Topiramate—obesity	0.000238	0.000649	CcSEcCtD
Tadalafil—Rash—Bupropion—obesity	0.000237	0.000646	CcSEcCtD
Tadalafil—Dermatitis—Bupropion—obesity	0.000237	0.000646	CcSEcCtD
Tadalafil—Shock—Topiramate—obesity	0.000236	0.000642	CcSEcCtD
Tadalafil—Headache—Bupropion—obesity	0.000236	0.000642	CcSEcCtD
Tadalafil—Nervous system disorder—Topiramate—obesity	0.000235	0.00064	CcSEcCtD
Tadalafil—Tachycardia—Topiramate—obesity	0.000234	0.000637	CcSEcCtD
Tadalafil—Skin disorder—Topiramate—obesity	0.000233	0.000634	CcSEcCtD
Tadalafil—Hyperhidrosis—Topiramate—obesity	0.000232	0.000631	CcSEcCtD
Tadalafil—Hypotension—Topiramate—obesity	0.000224	0.00061	CcSEcCtD
Tadalafil—Nausea—Bupropion—obesity	0.000223	0.000609	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Topiramate—obesity	0.000218	0.000595	CcSEcCtD
Tadalafil—Insomnia—Topiramate—obesity	0.000217	0.000591	CcSEcCtD
Tadalafil—Paraesthesia—Topiramate—obesity	0.000215	0.000586	CcSEcCtD
Tadalafil—Dyspnoea—Topiramate—obesity	0.000214	0.000582	CcSEcCtD
Tadalafil—Somnolence—Topiramate—obesity	0.000213	0.00058	CcSEcCtD
Tadalafil—Dyspepsia—Topiramate—obesity	0.000211	0.000575	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Topiramate—obesity	0.000207	0.000564	CcSEcCtD
Tadalafil—Fatigue—Topiramate—obesity	0.000207	0.000563	CcSEcCtD
Tadalafil—Pain—Topiramate—obesity	0.000205	0.000558	CcSEcCtD
Tadalafil—Constipation—Topiramate—obesity	0.000205	0.000558	CcSEcCtD
Tadalafil—Gastrointestinal pain—Topiramate—obesity	0.000196	0.000534	CcSEcCtD
Tadalafil—Urticaria—Topiramate—obesity	0.00019	0.000519	CcSEcCtD
Tadalafil—Abdominal pain—Topiramate—obesity	0.000189	0.000516	CcSEcCtD
Tadalafil—Hypersensitivity—Topiramate—obesity	0.000176	0.000481	CcSEcCtD
Tadalafil—Asthenia—Topiramate—obesity	0.000172	0.000468	CcSEcCtD
Tadalafil—Pruritus—Topiramate—obesity	0.000169	0.000462	CcSEcCtD
Tadalafil—Diarrhoea—Topiramate—obesity	0.000164	0.000447	CcSEcCtD
Tadalafil—Dizziness—Topiramate—obesity	0.000158	0.000432	CcSEcCtD
Tadalafil—Vomiting—Topiramate—obesity	0.000152	0.000415	CcSEcCtD
Tadalafil—Rash—Topiramate—obesity	0.000151	0.000412	CcSEcCtD
Tadalafil—Dermatitis—Topiramate—obesity	0.000151	0.000411	CcSEcCtD
Tadalafil—Headache—Topiramate—obesity	0.00015	0.000409	CcSEcCtD
Tadalafil—Nausea—Topiramate—obesity	0.000142	0.000388	CcSEcCtD
Tadalafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—obesity	0.000139	0.000683	CbGpPWpGaD
Tadalafil—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—obesity	0.000137	0.000674	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—AGT—obesity	0.000136	0.000669	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—CYP26B1—obesity	0.000136	0.000668	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HTR1B—obesity	0.000135	0.000663	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CRH—obesity	0.000135	0.000663	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—CYP26B1—obesity	0.000134	0.000659	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SDC1—obesity	0.000134	0.000656	CbGpPWpGaD
Tadalafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—obesity	0.000134	0.000655	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PRKCD—obesity	0.000133	0.000655	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—AKR1C3—obesity	0.000131	0.000645	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—HTR2A—obesity	0.00013	0.000641	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—C3—obesity	0.00013	0.00064	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PIK3CB—obesity	0.00013	0.00064	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NPS—obesity	0.000128	0.000629	CbGpPWpGaD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—obesity	0.000127	0.000621	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—F2—obesity	0.000126	0.000618	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—PRKCB—obesity	0.000126	0.000618	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HTR2C—obesity	0.000126	0.000617	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—DRD1—obesity	0.000126	0.000617	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—AGT—obesity	0.000124	0.000608	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NTRK2—obesity	0.000122	0.0006	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ADRB1—obesity	0.000122	0.000597	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—PIK3CG—obesity	0.000121	0.000592	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—ADH1B—obesity	0.000119	0.000586	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PARP1—obesity	0.000119	0.000585	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GHRL—obesity	0.000119	0.000585	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—DRD4—obesity	0.000118	0.00058	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—POMC—obesity	0.000115	0.000563	CbGpPWpGaD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—obesity	0.000114	0.000562	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—F2—obesity	0.000114	0.000562	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PRKCB—obesity	0.000114	0.000562	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CNR1—obesity	0.000113	0.000554	CbGpPWpGaD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—obesity	0.000113	0.000554	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TCF7L2—obesity	0.000111	0.000544	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—AKT2—obesity	0.00011	0.000541	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—DRD2—obesity	0.00011	0.00054	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PIK3CG—obesity	0.000109	0.000537	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GCG—obesity	0.000109	0.000535	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PTPN1—obesity	0.000109	0.000535	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—PIK3CD—obesity	0.000106	0.00052	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—TGFB1—obesity	0.000105	0.000514	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—POMC—obesity	0.000104	0.000512	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PRL—obesity	0.000104	0.00051	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—STK11—obesity	0.000102	0.000503	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CCL2—obesity	0.000102	0.000501	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PLG—obesity	0.000101	0.000497	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—RHOA—obesity	0.000101	0.000496	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—AKT2—obesity	0.0001	0.000492	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—PIK3R1—obesity	0.0001	0.000491	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—FOXO3—obesity	9.89e-05	0.000485	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ADRB2—obesity	9.86e-05	0.000484	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SOCS1—obesity	9.71e-05	0.000477	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PIK3CD—obesity	9.63e-05	0.000472	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SOCS3—obesity	9.59e-05	0.000471	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GNB3—obesity	9.39e-05	0.000461	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—TGFB1—obesity	9.33e-05	0.000458	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—TYK2—obesity	9.26e-05	0.000454	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—PIK3CB—obesity	9.24e-05	0.000453	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IGF2—obesity	9.22e-05	0.000453	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—SULT2A1—obesity	9.19e-05	0.000451	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—RHOA—obesity	9.18e-05	0.000451	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GNAS—obesity	9.14e-05	0.000449	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PIK3R1—obesity	9.09e-05	0.000446	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—SULT2A1—obesity	9.07e-05	0.000445	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—APOB—obesity	8.95e-05	0.000439	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PIK3CA—obesity	8.91e-05	0.000437	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCL5—obesity	8.74e-05	0.000429	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—GPX3—obesity	8.65e-05	0.000425	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—LPL—obesity	8.55e-05	0.00042	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—FOXO1—obesity	8.49e-05	0.000417	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—RPS6KB1—obesity	8.47e-05	0.000416	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PIK3CB—obesity	8.39e-05	0.000412	CbGpPWpGaD
Tadalafil—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—obesity	8.36e-05	0.00041	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PIK3CA—obesity	7.94e-05	0.00039	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PRKCD—obesity	7.88e-05	0.000387	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HTR2A—obesity	7.71e-05	0.000378	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—C3—obesity	7.7e-05	0.000378	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—AKR1C3—obesity	7.58e-05	0.000372	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IRS2—obesity	7.32e-05	0.000359	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—AGT—obesity	7.31e-05	0.000359	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—AKT1—obesity	7.28e-05	0.000357	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—LEP—obesity	7.17e-05	0.000352	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—APOE—obesity	7.17e-05	0.000352	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CAV1—obesity	7.1e-05	0.000349	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—APOA1—obesity	7.08e-05	0.000348	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ESR1—obesity	6.84e-05	0.000336	CbGpPWpGaD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—POMC—obesity	6.78e-05	0.000333	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—F2—obesity	6.76e-05	0.000332	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PRKCB—obesity	6.76e-05	0.000332	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—CYP2E1—obesity	6.72e-05	0.00033	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—BAD—obesity	6.68e-05	0.000328	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—CYP2E1—obesity	6.63e-05	0.000325	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—AKT1—obesity	6.49e-05	0.000318	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PIK3CG—obesity	6.47e-05	0.000317	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IRS1—obesity	6.39e-05	0.000314	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—GGT1—obesity	6.17e-05	0.000303	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—POMC—obesity	6.16e-05	0.000302	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—INS—obesity	6.12e-05	0.000301	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—NCOA1—obesity	6.08e-05	0.000298	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCL2—obesity	6.02e-05	0.000296	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—CYP19A1—obesity	5.99e-05	0.000294	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IGF1—obesity	5.92e-05	0.000291	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—AKT2—obesity	5.92e-05	0.00029	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—CYP19A1—obesity	5.91e-05	0.00029	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PIK3CD—obesity	5.69e-05	0.000279	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—PIK3CA—obesity	5.63e-05	0.000276	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SERPINE1—obesity	5.62e-05	0.000276	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CA3—obesity	5.6e-05	0.000275	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—COMT—obesity	5.57e-05	0.000273	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—COMT—obesity	5.49e-05	0.00027	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TYK2—obesity	5.47e-05	0.000268	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—RHOA—obesity	5.43e-05	0.000266	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PIK3R1—obesity	5.37e-05	0.000264	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NOS3—obesity	5.37e-05	0.000264	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PIK3CA—obesity	5.11e-05	0.000251	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PIK3CB—obesity	4.96e-05	0.000243	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MTOR—obesity	4.96e-05	0.000243	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GLRX—obesity	4.77e-05	0.000234	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—AKT1—obesity	4.6e-05	0.000226	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—IL6—obesity	4.53e-05	0.000222	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MMP9—obesity	4.31e-05	0.000211	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—OTC—obesity	4.25e-05	0.000208	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—INSIG2—obesity	4.25e-05	0.000208	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PPM1L—obesity	4.25e-05	0.000208	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ETFDH—obesity	4.25e-05	0.000208	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MAPK8—obesity	4.19e-05	0.000206	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—AKT1—obesity	4.18e-05	0.000205	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GPT—obesity	3.88e-05	0.000191	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—UQCRC2—obesity	3.88e-05	0.000191	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—INPP5E—obesity	3.88e-05	0.000191	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—STAT3—obesity	3.83e-05	0.000188	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SUCLG2—obesity	3.61e-05	0.000177	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ME1—obesity	3.61e-05	0.000177	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALDH6A1—obesity	3.61e-05	0.000177	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—POMC—obesity	3.6e-05	0.000177	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MYC—obesity	3.56e-05	0.000175	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TGFB1—obesity	3.55e-05	0.000174	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—UCP1—obesity	3.4e-05	0.000167	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PNPLA3—obesity	3.4e-05	0.000167	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—COX7C—obesity	3.4e-05	0.000167	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—DGAT2—obesity	3.22e-05	0.000158	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CS—obesity	3.22e-05	0.000158	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CPS1—obesity	3.22e-05	0.000158	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SUCLA2—obesity	3.22e-05	0.000158	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—LIPE—obesity	3.07e-05	0.000151	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—MUT—obesity	3.07e-05	0.000151	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PIK3CA—obesity	3.02e-05	0.000148	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYB5A—obesity	2.94e-05	0.000145	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—DGAT1—obesity	2.94e-05	0.000145	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ACLY—obesity	2.83e-05	0.000139	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ENPP1—obesity	2.74e-05	0.000134	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALOX12—obesity	2.74e-05	0.000134	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IL6—obesity	2.68e-05	0.000131	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HMGCS1—obesity	2.65e-05	0.00013	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PFKFB3—obesity	2.57e-05	0.000126	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PLIN1—obesity	2.57e-05	0.000126	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SAT1—obesity	2.57e-05	0.000126	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PNPLA2—obesity	2.57e-05	0.000126	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ANGPTL4—obesity	2.57e-05	0.000126	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ACADM—obesity	2.57e-05	0.000126	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—OXCT1—obesity	2.5e-05	0.000123	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYTB—obesity	2.5e-05	0.000123	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ACACB—obesity	2.5e-05	0.000123	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—AKT1—obesity	2.47e-05	0.000121	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PNLIP—obesity	2.44e-05	0.00012	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SRD5A1—obesity	2.44e-05	0.00012	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SDC3—obesity	2.38e-05	0.000117	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—STS—obesity	2.33e-05	0.000114	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP26B1—obesity	2.33e-05	0.000114	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HK2—obesity	2.33e-05	0.000114	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PPARD—obesity	2.28e-05	0.000112	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SLC27A1—obesity	2.23e-05	0.00011	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—FABP4—obesity	2.19e-05	0.000107	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GLUL—obesity	2.19e-05	0.000107	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—UCP3—obesity	2.07e-05	0.000102	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—UCP2—obesity	2.07e-05	0.000102	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HSD11B1—obesity	2.07e-05	0.000102	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ECHS1—obesity	2.07e-05	0.000102	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ADH1B—obesity	2.04e-05	0.0001	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ACSL1—obesity	2.01e-05	9.86e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GPAM—obesity	2.01e-05	9.86e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PPARGC1B—obesity	2.01e-05	9.86e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—FADS1—obesity	1.95e-05	9.57e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HADH—obesity	1.95e-05	9.57e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PCK1—obesity	1.95e-05	9.57e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ACP5—obesity	1.9e-05	9.31e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—G6PD—obesity	1.85e-05	9.07e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SREBF2—obesity	1.83e-05	8.96e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HK1—obesity	1.83e-05	8.96e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—LPA—obesity	1.76e-05	8.66e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—LPIN1—obesity	1.73e-05	8.47e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—APOA5—obesity	1.69e-05	8.3e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CLOCK—obesity	1.61e-05	7.92e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SLC22A1—obesity	1.61e-05	7.92e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GLP1R—obesity	1.57e-05	7.72e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SULT2A1—obesity	1.57e-05	7.72e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—DPYD—obesity	1.55e-05	7.59e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PRKAR2B—obesity	1.49e-05	7.31e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—DCN—obesity	1.48e-05	7.25e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CPT1A—obesity	1.44e-05	7.06e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—NAMPT—obesity	1.41e-05	6.92e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—LIPC—obesity	1.4e-05	6.88e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GCK—obesity	1.4e-05	6.88e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—APOC3—obesity	1.39e-05	6.83e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CETP—obesity	1.35e-05	6.64e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SDC1—obesity	1.34e-05	6.56e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—AKR1C3—obesity	1.32e-05	6.45e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SCARB1—obesity	1.29e-05	6.35e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SREBF1—obesity	1.26e-05	6.17e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GOT2—obesity	1.22e-05	6e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—FASN—obesity	1.2e-05	5.87e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—BCHE—obesity	1.19e-05	5.85e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP2E1—obesity	1.15e-05	5.64e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—NQO1—obesity	1.14e-05	5.58e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GCG—obesity	1.09e-05	5.35e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SLC2A4—obesity	1.09e-05	5.35e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYCS—obesity	1.08e-05	5.28e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GGT1—obesity	1.06e-05	5.18e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GOT1—obesity	1.06e-05	5.18e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—NCOA1—obesity	1.04e-05	5.1e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—STK11—obesity	1.02e-05	5.03e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP19A1—obesity	1.02e-05	5.03e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—COMT—obesity	9.52e-06	4.67e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PPARGC1A—obesity	9.39e-06	4.61e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GNB3—obesity	9.39e-06	4.61e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HMOX1—obesity	9.35e-06	4.59e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GNAS—obesity	9.14e-06	4.49e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—APOB—obesity	8.96e-06	4.4e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—LPL—obesity	8.55e-06	4.2e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GPX1—obesity	8.34e-06	4.09e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CD36—obesity	8.12e-06	3.99e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—MTHFR—obesity	7.7e-06	3.78e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PPARA—obesity	7.55e-06	3.71e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—AGT—obesity	7.32e-06	3.59e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—APOE—obesity	7.17e-06	3.52e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CAV1—obesity	7.1e-06	3.49e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—APOA1—obesity	7.09e-06	3.48e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PIK3CG—obesity	6.47e-06	3.17e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PPARG—obesity	6.24e-06	3.06e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—POMC—obesity	6.16e-06	3.02e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—INS—obesity	6.12e-06	3.01e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PIK3CD—obesity	5.69e-06	2.79e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALB—obesity	5.61e-06	2.76e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—NOS3—obesity	5.37e-06	2.64e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PIK3R1—obesity	5.37e-06	2.64e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PIK3CB—obesity	4.96e-06	2.43e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PTGS2—obesity	4.91e-06	2.41e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PIK3CA—obesity	3.02e-06	1.48e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—AKT1—obesity	2.47e-06	1.21e-05	CbGpPWpGaD
